Compare INNIO N.V. Ordinary Shares (INIO) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
INNIO N.V. Ordinary Shares vs uniQure N.V. Ordinary Shares — how do they compare? INNIO N.V. Ordinary Shares trades at $16 (market cap $13.73B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.48B). The key difference: INNIO N.V. Ordinary Shares is far larger — about 9.3× uniQure N.V. Ordinary Shares's market cap, and uniQure N.V. Ordinary Shares is trading nearer its 52-week high, INNIO N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold INNIO N.V. Ordinary Shares for 0 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| INIO | QURE | |
|---|---|---|
Market Cap | $13.73B | $1.48B |
Volume | 5,012,195 | 2,488,780 |
Sector | Industrials | Health |
52-Week High | $41.13 | $70.59 |
52-Week Low | $16.50 | $9.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $15.39B | $728.62M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About INNIO N.V. Ordinary Shares
INNIO Group designs, manufactures, and services reciprocating gas engines for distributed power generation under its Jenbacher and Waukesha brands, serving applications from data centers to industrial and grid-stabilization uses.
Read more on INIO →About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →
